Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05806996 · ClinicalTrials.gov registry record · Phase 2
A Study of Magnesium and Bladder Spasms Following Ambulatory Urologic Procedures
A Phase 2 study of Bladder Spasms, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT05806996 is a Phase 2 study of Bladder Spasms that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 120 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05806996, a Phase 2 study of Bladder Spasms, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This research is being done to find out whether intravenous magnesium is effective in the treatment of bladder spasms after urologic surgery.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Magnesium
Study Locations (1)
Minnesota
- Mayo Clinic in Minnesota - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2023-07-31 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05806996
The ClinicalTrials.gov registry entry for NCT05806996 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bladder Spasms appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05806996 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05806996 about?
NCT05806996 is a clinical study titled "A Study of Magnesium and Bladder Spasms Following Ambulatory Urologic Procedures". This research is being done to find out whether intravenous magnesium is effective in the treatment of bladder spasms after urologic surgery.
What is the current status of trial NCT05806996?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2023-07-31. Estimated completion is 2026-12-31.
What conditions does trial NCT05806996 study?
This clinical trial studies the following conditions: Bladder Spasms.
What interventions are being tested in trial NCT05806996?
The interventions under investigation include: Placebo (DRUG), Magnesium (DRUG).
Who is sponsoring clinical trial NCT05806996?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05806996 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.